Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study

---

Atıf İçin Kopyala

Oncel I., SANCAR M., KONUŞKAN B. , Arioz F., TEZCAN S., ARMAN KANDIRMAZ E., ...Daha Fazla

PEDIATRIC NEUROLOGY, cilt.110, ss.59-63, 2020 (SCI İndekslerine Giren Dergi)

• Cilt numarası: 110
• Basım Tarihi: 2020
• Doi Numarası: 10.1016/j.pediatrneurol.2020.05.009
• Dergi Adı: PEDIATRIC NEUROLOGY
• Sayfa Sayıları: ss.59-63

Özet

Background: Aprepitant is a neurokinin-1 receptor antagonist approved for the treatment of chemotherapy-induced nausea. We aimed to investigate the safety and efficacy of aprepitant in patients with subacute sclerosing panencephalitis.